Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Intergroup analysis revealed significant differences in age, AVF vintage, PTH, phosphorus, uric acid levels and history of vitamin D analogs, CVD (all P < 0.05, Table 1).
Source: Results. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cohort study.
Cohort study
Examines exposures and outcomes over time within a defined group.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Patients were divided into four groups based on serum phosphorus levels (<1.33 mmol/L, 1.33 to 1.61 mmol/L, 1.61 to 1.965 mmol/L, > 1.965 mmol/L).
Source: Abstract.
This retrospective cohort study enrolled 239 MHD patients who had AVF creation at Affiliated Hospital of Changchun University of Chinese Medicine from June 2019 to June 2023 ().
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Hyperphosphatemia as a potential risk factor for arteriovenous fistula dysfunction: A retrospective study in hemodialysis patients
Cohort study · PLOS One · 2025
Original publication title
Hyperphosphatemia as a potential risk factor for arteriovenous fistula dysfunction: A retrospective study in hemodialysis patients
© 2025 Jiang et al
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
The study investigates the relationship between Hyperphosphatemia and arteriovenous fistula dysfunction in patients undergoing maintenance hemodialysis.
Source: BackgroundAbstract: What methods does the paper describe?
Data were collected from patients who had their first arteriovenous fistula creation and regular maintenance hemodialysis between 2019 and 2023. Patients were divided into four groups based on serum phosphorus levels (<1.33 mmol/L, 1.33 to 1.61 mmol/L, 1.61 to 1.965 mmol/L, > 1.965 mmol/L). Statistical methods included Kaplan-Meier survival curves, Cox proportional hazards regression models, and Restricted Cubic Spline.
Source: MethodsAbstract: Results
The study included 239 patients. Kaplan-Meier survival curves showed that Hyperphosphatemia significantly correlated with arteriovenous fistula dysfunction (P = 0.0052). Cox univariate analysis showed phosphorus (HR = 3.16, P < 0.001) is risk factor of arteriovenous fistula dysfuntion. Multivariate Cox regression analysis further confirmed high phosphorus levels were an independent risk factor of AVF dysfuntion (P for trend<0.001). Restricted Cubic Spline showed a nonlinear relationship between phosphorus levels and arteriovenous fistula dysfunction (P for non-linearity = 0.024), with a cutoff point at 1.544 mmol/L (LR = 0.035).
Source: ResultsAbstract: Conclusion
Hyperphosphatemia is an independent risk factor for arteriovenous fistula dysfunction, emphasizing the need for clinical practice to pay attention to the impact of mineral metabolism disorders on the integrity of arteriovenous fistula and to strengthen phosphate management.
Source: ConclusionAuthors’ abstract
Background
The study investigates the relationship between Hyperphosphatemia and arteriovenous fistula dysfunction in patients undergoing maintenance hemodialysis.
Methods
Data were collected from patients who had their first arteriovenous fistula creation and regular maintenance hemodialysis between 2019 and 2023. Patients were divided into four groups based on serum phosphorus levels (<1.33 mmol/L, 1.33 to 1.61 mmol/L, 1.61 to 1.965 mmol/L, > 1.965 mmol/L). Statistical methods included Kaplan-Meier survival curves, Cox proportional hazards regression models, and Restricted Cubic Spline.
Results
The study included 239 patients. Kaplan-Meier survival curves showed that Hyperphosphatemia significantly correlated with arteriovenous fistula dysfunction (P = 0.0052). Cox univariate analysis showed phosphorus (HR = 3.16, P < 0.001) is risk factor of arteriovenous fistula dysfuntion. Multivariate Cox regression analysis further confirmed high phosphorus levels were an independent risk factor of AVF dysfuntion (P for trend<0.001). Restricted Cubic Spline showed a nonlinear relationship between phosphorus levels and arteriovenous fistula dysfunction (P for non-linearity = 0.024), with a cutoff point at 1.544 mmol/L (LR = 0.035).
Conclusion
Hyperphosphatemia is an independent risk factor for arteriovenous fistula dysfunction, emphasizing the need for clinical practice to pay attention to the impact of mineral metabolism disorders on the integrity of arteriovenous fistula and to strengthen phosphate management.
Publication and source details
Original title: Hyperphosphatemia as a potential risk factor for arteriovenous fistula dysfunction: A retrospective study in hemodialysis patients
Yujie Jiang; Chengji Cui; He Nan; Tianying Chang; Fan Li; Shoulin Zhang
PLOS One · 2025
Competing Interests: The authors have declared that no competing interests exist.
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T01:55:02.978749+00:00
DOI: 10.1371/journal.pone.0335599 · PMC12574839